A Proposal for an Ultrasensitive Label-Free Optical BioMEMS Platform Based on a DBR-Michelson Interferometer for Cancer Detection and Therapeutic Applications
Sensors · 2026
DOI: 10.3390/s26185913 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sensors, 2026. Verfasst von Bocar Ndiaye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Institute for Technological Innovation (3IT), Faculty of Engineering, Université de Sherbrooke, Sherbrooke, QC J1K 0A5, Canada. Hauptthemen laut MEDLINE: Interferometry, Biosensing Techniques, Neoplasms, Micro-Electrical-Mechanical Systems. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Hecht Foundation.
Abstract (Originalsprache)
Early detection of cancer remains challenging due to the extremely low concentration of biomarkers present during initial disease stages. Dysregulation of key signaling pathways, including cyclin-dependent kinase (CDK) networks, drives uncontrolled cell proliferation and tumor progression, underscoring the need for highly sensitive, label-free biosensing technologies. Conventional analytical methods such as ELISA and PCR offer reliable detection but require complex sample preparation, fluorescent labeling, and long processing times, limiting their suitability for rapid diagnostics. This work introduces a novel label-free Biological Micro-Opto-Electro-Mechanical System (BioMEMS) platform based on an unbalanced Michelson interferometer with DBR mirrors to interrogate the minute spectral shifts induced by biomolecular interactions. A microcantilever is suspended above a silicon-on-insulator (SOI) waveguide, where the specific binding of biomarkers generates compressive surface stress, causing a downward deflection that reduces the cantilever-to-waveguide gap. This displacement modulates the effective refractive index of the sensing arm through enhanced evanescent-field coupling. The resulting phase variation is further detected through the high-sensitivity Michelson interferometric architecture, enabling ultrasensitive spectral interrogation. Numerical simulations using COMSOL Multiphysics demonstrate a narrow full width at half maximum (FWHM) of 27.6 nm, a quality factor (Q) of 53.34, and an overall sensitivity of 75.74 µm/(N/m). These results highlight the potential of the proposed platform for early cancer detection and precise monitoring of dysregulated signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interdisciplinary Institute for Technological Innovation (3IT), Faculty of Engineering, Université de Sherbrooke, Sherbrooke, QC J1K 0A5, Canada.
- Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 2B5, Canada.
- Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences and Centre de Recherche du CHUS, Université de Sherbrooke, Sherbrooke, QC J1E 4K8, Canada.
- Université de Sherbrooke Cancer Research Institute (IRCUS), Sherbrooke, QC J1E 4K8, Canada.
- Laboratoire Nanotechnologies Nanosystemes (LN2), Université de Sherbrooke, Sherbrooke, QC J1K 0A5, Canada.
ORCID-Profile: Naima Brahiti, Kazem Nouri, Kian Jafari
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Hecht Foundation
Zitieren
APA
Ndiaye, B., Brahiti, N., Nouri, K., Azad, T., & Jafari, K. (2026). A Proposal for an Ultrasensitive Label-Free Optical BioMEMS Platform Based on a DBR-Michelson Interferometer for Cancer Detection and Therapeutic Applications. Sensors. https://doi.org/10.3390/s26185913
Vancouver
Ndiaye B, Brahiti N, Nouri K, Azad T, Jafari K. A Proposal for an Ultrasensitive Label-Free Optical BioMEMS Platform Based on a DBR-Michelson Interferometer for Cancer Detection and Therapeutic Applications. Sensors. 2026. doi:10.3390/s26185913
BibTeX
@article{Ndiaye2026,
author = {Ndiaye, Bocar and Brahiti, Naima and Nouri, Kazem and Azad, Taha and Jafari, Kian},
title = {A Proposal for an Ultrasensitive Label-Free Optical BioMEMS Platform Based on a DBR-Michelson Interferometer for Cancer Detection and Therapeutic Applications},
journal = {Sensors},
year = {2026},
doi = {10.3390/s26185913}
}
EUVIMED